Business
Currency:HKD
2024/H1
Stock NameRevenueRatio
生产及销售制药科技产品3.77B62.39%
销售生物技术产品1.93B31.94%
销售核药抗肿瘤诊疗及心脑血管精准介入诊疗科技产品342.75M5.67%
Product
No Data
Region
Currency:HKD
2024/H1
Stock NameRevenueRatio
China5.1B84.42%
America403.34M6.67%
Europe275.75M4.56%
Asia (excl. China)236.1M3.90%
Other27.2M0.45%